Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Naltrexone for Early Problem Drinkers Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Naltrexone for Early Problem Drinkers conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Naltrexone for Early Problem Drinkers Clinical research trials and Naltrexone for Early Problem Drinkers healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Naltrexone for Early Problem Drinkers. Naltrexone for Early Problem Drinkers Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Naltrexone for Early Problem Drinkers clinical trial. Participants typically obtain the most effective healthcare available for their Naltrexone for Early Problem Drinkers condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.

Home > "N" Clinical Trials Conditions > Naltrexone for Early Problem Drinkers

Naltrexone for Early Problem Drinkers



Naltrexone for Early Problem Drinkers

For Condition: Alcoholism
Status: Completed
Sponsor(s): National Institute on Alcohol Abuse and Alcoholism (NIAAA) ,
Synopsis: Early problem drinkers are prevalent in the United States. Recent controlled trials have shown that brief interventions in the primary care setting can reduce drinking and alcohol-related problems in patients who lack evidence of alcohol dependence. Although naltrexone (Revia) has been approved for the treatment of alcohol dependence, few pharmacotherapy studies have been undertaken with early problem drinkers. This study is an 8-week trial of naltrexone versus placebo, combined with coping skills treatment that either focuses on targeted use of medication or serves as background to daily use of the medication. A total of 160 early problem drinkers recruited through screening in primary care medical settings will be randomly assigned to one of four treatment groups. Followup evaluations will be conducted at the end of treatment and again 3, 6, and 12 months.
Details:
Eligibility:
Study Type:  Interventional, Treatment, Randomized, Placebo Control, Efficacy Study
Minimum Age/Maximum Age: 18 Years/60 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Limited to early problem drinkers (i.e., those with no more than mild alcohol dependence). - Have an average weekly alcohol consumption of greater than or equal to 24 standard drinks for men and 18 standard drinks for women. - Able to read English at the eighth grade or higher level and show no evidence of significant cognitive impairment. - Willing to provide a collateral informant for interviews regarding the patient's drinking during the study. - A woman of child-bearing potential must be non-lactating, practicing a reliable method of birth control, and have a negative pregnancy test prior to initiation of treatment. - Willing to provide a signed informed consent to participate in the study. Exclusion Criteria: - Have a current clinically significant physical disease or abnormality. - Have a serious psychiatric illness. - Have a current diagnosis of drug dependence (other than nicotine dependence) or a lifetime diagnosis of opioid dependence. - A current diagnosis of alcohol dependence that is moderate or greater in severity or a history of alcohol withdrawal, or recurrent use of alcohol to alleviate alcohol withdrawal symptoms. - Used opioids or other psychoactive medications regularly in the month prior to study enrollment. - History of hypersensitivity to naltrexone (Revia).
Total Enrollment: 160

Location and Contact Information:

Department of Psychiatry, University of Connecticut Health Center
Farmington,  Connecticut,  06030
United States
 


Additional Information:
Study ID Numbers:  NIAAAKRA11062; 
Study Start Date: 
Record last reviewed: April 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000455

Other Alcoholism Studies:
1. Acamprosate Treatment: Mechanisms of Action

2. Sertraline and Naltrexone for Alcohol Dependence

3. Behavioral Counseling for Alcohol Dependent Smokers (nicotine patch)

4. Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion)

5. Naltrexone for Early Problem Drinkers

Related Studies:

Other Alcoholism Clinical Trials
Other Connecticut Clinical Trials
Other Farmington Clinical Trials

Naltrexone for Early Problem Drinkers
Modify your Search

  Other Alcoholism Clinical Trials
  Other Connecticut Clinical Trials
  Other Farmington Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103